黄龙止咳颗粒通过调控巨噬细胞极化治疗儿童咳嗽变异性哮喘及其机制研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:

河北省卫生健康委科研基金项目(20220370);


The mechanism and treatment of cough variant asthma in children with huanglong zhike granules by regulating macrophage polarization
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:基于巨噬细胞极化探究黄龙止咳颗粒治疗儿童咳嗽变异性哮喘的疗效及作用机制。方法:将160例咳嗽变异性哮喘患儿分为对照组和实验组,每组各80例。对照组予以孟鲁司特钠咀嚼片及黄龙止咳颗粒模拟剂治疗;实验组予以孟鲁司特钠咀嚼片及黄龙止咳颗粒治疗,均连续治疗4周。于治疗结束后以咳嗽严重程度评分、中医证候评分、肺功能指标、气道解剖学指标的变化评定临床疗效,并比较两组患儿治疗前后外周血M1型、M2型巨噬细胞比例及巨噬细胞极化标记基因表达量,统计患儿治疗期间嗜睡、腹泻等并发症发生情况。结果:治疗后,实验组咳嗽严重程度评分、中医证候评分均低于对照组(P<0.05),FEV1、FVC、FEV1/FVC及PEF均高于对照组(P<0.05);实验组气道壁厚度、基底膜厚度、气道壁总面积小于对照组(P<0.05);实验组M1型巨噬细胞比例低于对照组(P<0.05),M2型巨噬细胞比例高于对照组(P<0.05);实验组Arg-1、iNOS、CD80、CD163 mRNA表达量均低于对照组(P<0.05)。治疗期间,实验组出现头痛1例,不良反应发生率为1.25%;对照组出现嗜睡1例,腹泻1例,不良反应发生率为2.50%。两组不良反应总发生率无统计学差异(P>0.05)。结论:黄龙止咳颗粒可通过调控巨噬细胞极化作用治疗儿童咳嗽变异性哮喘,并能减轻咳嗽严重程度,改善肺功能及气道功能。

    Abstract:

    Objective:To explore the effect and mechanism of Huanglong Zhike Granules in the treatment of cough variant asthma in children based on macrophage polarization.Methods:160 children with cough variant asthma were divided into a con-trol group and an experimental group,with 80 cases in each group.The control group was given montelukast sodium chewable tablets and Huanglong Zhike Granules placebo,and the experimental group was given montelukast sodium chewable tablets and Huanglong Zhike Granules,both groups received continuous treatment for 4 weeks.After treatment,the clinical efficacy was e-valuated by changes in cough severity score,TCM syndrome score,pulmonary function indicators,and airway anatomical indica-tors.The proportions of M1 and M2 macrophages in peripheral blood and the expression levels of macrophage polarization marker genes before and after treatment were compared between the two groups.The occurrence of complications such as drowsiness and diarrhea during the treatment period was statistically analyzed.Results:After treatment,the cough severity score and TCM syndrome score in the experimental group were lower than those in the control group,and FEV1,FVC,FEV1/FVC,and PEF were higher than those in the control group(P<0.05).After treatment,the airway wall thickness,basement mem-brane thickness,and total airway wall area in the experimental group were smaller than those in the control group(P<0.05).After treatment,the proportion of M1 macrophages in the experimental group was lower than that in the control group,and the proportion of M2 macrophages was higher than that in the control group(P<0.05).After treatment,the mRNA expression levels of Arg-1,iNOS,CD80,and CD163 in the experimental group were lower than those in the control group(P<0.05).Dur-ing the treatment period,1 case of headache occurred in the experimental group,with an incidence of adverse reactions of 1.25%,1 case of drowsiness and 1 case of diarrhea occurred in the control group,with an incidence of adverse reactions of 2.50%.There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Huanglong Zhike Granules can treat cough variant asthma in children by regulating macrophage polarization,and can reduce cough severity and improve lung function and airway function.

    参考文献
    相似文献
    引证文献
引用本文

张晓红;李新;赵荣华;韩宁宁;.黄龙止咳颗粒通过调控巨噬细胞极化治疗儿童咳嗽变异性哮喘及其机制研究[J].川北医学院学报,2025,40(11):1403-1407+1412.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-22
  • 出版日期:
文章二维码